Commentary on: Carboxyhemoglobinemia in a pediatric cardiac surgery patient derived from a contaminated unit of allogenic blood

McRobb, C.
July 2011
Perfusion;Jul2011, Vol. 26 Issue 4, p308
Academic Journal
No abstract available.


Related Articles

  • Carboxyhemoglobinemia in a pediatric cardiopulmonary bypass patient derived from a contaminated unit of allogenic blood. McRobb, C.; Walczak, R.; Lawson, S.; Lodge, A.; Lockhart, E.; Bandarenko, N.; Ing, R. // Perfusion;Jul2011, Vol. 26 Issue 4, p302 

    A 4.3 kg, three-month-old patient, diagnosed with a perimembranous ventricular septal defect, presented for cardiac surgery. Upon initiation of cardiopulmonary bypass (CPB), the patient developed carboxyhemoglobinemia (11.1%). Potential sources for the unexpected acquired carboxyhemoglobinemia...

  • Initial results of an optimized perfusion system. Starck, CT; Bettex, D; Felix, C; Reser, D; Dreizler, T; Hasenclever, P; Falk, V // Perfusion;Jul2013, Vol. 28 Issue 4, p292 

    Background: In order to reduce the negative effects of extracorporeal circulation (ECC), the perfusion system andmanagement were optimized at our institution. The goals of optimization were a reduction in the priming volume, in theforeign surface area and in microbubble activity, as well as...

  • Monitoring controversies during cardiopulmonary bypass: how far have we come? Stammers, A.H. // Perfusion;1998, Vol. 13 Issue 1, p35 

    Investigates the use of monitoring devices during cardiopulmonary bypass. Economic factors affecting monitoring decisions; Review of monitoring regarding patient outcome indicators; Evaluation of in-line blood gas monitoring.

  • Retrospective analysis of effect of low-dose aprotinin priming on allogeneic blood transfusion in repeated cardiac operations. Miyashita, T.; Hayashi, Y.; Ohnishi, Y.; Kuro, M. // Perfusion;1999, Vol. 14 Issue 3, p189 

    The objective of this retrospective study was to investigate efficacy of low-dose aprotinin priming therapy on the requirement of allogeneic transfusion and to identify risk factors for allogeneic transfusion in patients undergoing repeated cardiac operations. The present study includes a...

  • Leukocyte reduction in cardiovascular surgery. Morris, S. // Perfusion;Sep2001, Vol. 16 Issue 5, p371 

    Discusses the use of leucocyte reduction filters in cardiopulmonary bypass (CPB) surgery. Development of leukocyte filters; Effect of leukocyte reduction on bleeding/blood transfusions; Leukocyte reduction of blood cardioplegia; Leukocyte reduction in lung transplantation.

  • A new top-loading venous bag provides vacuum-assisted venous drainage. Tamari, Y; Lee-Sensiba, K; Beck, J; Chan, R; Salogub, M; Hall, M; Lee, T; Ganju, R; Mongero, L // Perfusion;Sep2002, Vol. 17 Issue 5, p383 

    A new venous bag has been developed, prototyped, and tested. The new bag has its inlet, outlet purge, and infusion tubes extending upward from the top of the bag, and are threaded through, bonded to, and sealed within a flat rigid top plate. This design allows the bag to be hung from its top...

  • Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. Levy, Jerrold H. // American Journal of Health-System Pharmacy;9/15/2005 Supplement 4, Vol. 62, pS15 

    Purpose. The pharmacologic management of hemostasis in patients undergoing surgery with cardiopulmonary bypass is discussed. Summary. Nearly 45 studies involving 7,000 patients have reported efficacy of aprotinin in blood conservation. Both in primary coronary artery bypass graft (CABG)...

  • Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Brinks, H.; Weerwind, P.; Bogdan, S.; Verbruggen, H.; Brouwer, M. // Perfusion;Jan2001, Vol. 16 Issue 1, p3 

    In this clinical pilot study, the influence of heparin pretreatment on the haemostatic system during and after cardiopulmonary bypass (CPB) was investigated. Thirteen patients scheduled for elective coronary artery bypass grafting (CABG) were divided into two groups: heparin pretreated (HP, n =...

  • Platelet Function in Stored Heparinised Autologous Blood Is Not Superior to in Patient Platelet Function during Routine Cardiopulmonary Bypass. Huet, Rolf C. G. Gallandat; De Vries, Adrianus J.; Cernak, Vladimir; Lisman, Ton // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: In cardiac surgery, cardiopulmonary bypass (CPB) and unfractionated heparin have negative effects on blood platelet function. In acute normovolemic haemodilution autologous unfractionated heparinised blood is stored ex-vivo and retransfused at the end of the procedure to reduce...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics